Release Date: 02/09/16 11:24 Summary: Company Update - Existing Agreements-TV2.AX Price Sensitive: Yes Download Document 112.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%